128KRW
13.91 BKRW
36.31 BKRW
87.63 M
About TELCON RF PHARM
Sector
Industry
CEO
Ji-Hoon Kim
Website
Headquarters
Yongin-si
Employees (FY)
122
Founded
1999
ISIN
KR7200230001
FIGI
BBG007D1S7M7
TELCON RF PHARMACEUTICAL. Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. It operates through the Radio frequency (RF) business division and Pharmaceutical and bio-pharmaceutical business division. The RF business division provides connectors, cable assemblies and components. The Pharmaceutical and bio-pharmaceutical business division offers algicell solution, gud solution, livamax suspension and other drugs. The company was founded on January 8, 1999 and is headquartered in Yongin-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 200230 is 706 KRW — it has decreased by 4.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange TELCON RF PHARM stocks are traded under the ticker 200230.
Yes, you can track TELCON RF PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 200230 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELCON RF PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 122.00 employees. See our rating of the largest employees — is TELCON RF PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELCON RF PHARM EBITDA is 5.21 B KRW, and current EBITDA margin is 14.35%. See more stats in TELCON RF PHARM financial statements.